Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 3, 2010, Pages 583-589

  Dunlap, Neal E ^b   Larner, James M ^b   Read, Paul W ^b   Kozower, Benjamin D ^a   Lau, Christine L ^a   Sheng, Ke ^b   Jones, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER STAGING; CLINICAL PROTOCOL; COMPARATIVE STUDY; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECURRENT CANCER; RETROSPECTIVE STUDY; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TOMOTHERAPY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; CARCINOMA, NON-SMALL-CELL LUNG; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RISK ASSESSMENT; RISK FACTOR; TIME; TUMOR RECURRENCE; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRGINIA; KAPLAN-MEIER ESTIMATE;

EID: 77955981793     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.046     Document Type: Article

References (25)

1. C.F. Mountain A new international staging system for lung cancer Chest 89 1986 225S 233S
2. T. Naruke, T. Goya, R. Tsuchiya, and K. Suemasu Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
3. A. Dominguez-Ventura, S.D. Cassivi, M.S. Allen, D.A. Wigle, F.C. Nichols, and P.C. Pairolero Lung cancer in octogenarians: factors affecting long-term survival following resection Eur J Cardiothoacr Surg 32 2007 370 374
4. P.G. Sanchez, G.S. Vendrame, G.R. Madke, E.S. Pilla, J. Camargo Jde, and C.F. Andrade Lobectomy for treating bronchial carcinoma: analysis of comorbidities and their impact on postoperative morbidity and mortality J Bras Pneumol 32 2006 495 504
5. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer Ann Thorac Surg 60 1995 615 623
6. P. Coy, and G.M. Kennelly The role of curative radiotherapy in the treatment of lung cancer Cancer 45 1980 698 702
7. D.E. Dosoretz, M.J. Katin, P.H. Blitzer, J.H. Rubenstein, S. Salenius, and M. Rashid Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies Int J Radiat Oncol Biol Phys 24 1992 3 9
8. R. Timmerman, L. Papiez, R. McGarry, L. Likes, C. DesRosier, and S. Frost Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
9. F.B. Zimmermann, H. Geinitz, S. Schill, A. Grosu, U. Schratzenstaller, and M. Molls Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer Lung Cancer 48 2005 107 114
10. P. Fritz, H. Kraus, T. Blaschke, W. Mühlnickel, K. Strauch, and W. Engel-Riedel Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning Lung Cancer 60 2008 193 199
11. A.J. Fakiris, R.C. McGarry, C.T. Yiannoutsos, L. Papiez, M. Williams, M.A. Henderson, and R. Timmerman Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
12. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
13. C. Konaka, N. Ikeda, and T. Hiyoshi Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation Lung Cancer 21 1998 185 191
14. N. Martini, M. Bains, M. Burt, M. Zakowski, P. McCormack, and V. Rusch Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
15. Y. Chen, W. Guo, Y. Lu, and B. Zoub Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy Radiother Oncol 88 2008 351 358
16. T. Inoue, S. Shimizu, R. Onimaru, A. Takeda, H. Onishi, and Y. Nagata Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687
17. P. Baumann, J. Nyman, M. Hoyer, B. Wennberg, G. Gagliardi, and I. Lax Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
18. I.S. Grills, D.L. Fitch, N.S. Goldstein, D. Yan, G.W. Chmielewski, and R.J. Welsh Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: implications for defining the clinical target volume (CTV) for radiotherapy Int J Radiat Oncol Biol Phys 63 2005 S99 100
19. S.S. Shim, K.S. Lee, and B.T. Kim Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging Radiology 236 2005 1011 1019
20. R.D. Timmerman, C. Park, and B.D. Kavanagh The North American experience with stereotactic body radiation therapy in non-small cell lung cancer J Clin Oncol 2 2007 S101 S112
21. K. Kubota, S. Yamada, K. Ishiwata, M. Ito, and T. Ido Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer Clin Nucl Med 17 1992 877 881
22. K. Kubota, S. Yamada, K. Ishiwata, M. Ito, T. Fujiwara, and H. Fukuda Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study Eur J Nucl Med 20 1993 495 501
23. M.P. Mac Manus, R.J. Hicks, J.P. Matthews, A. McKenzie, D. Rischin, and E.K. Salminen Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292
24. D.J. Hoopes, M. Tann, J.W. Fletcher, J.A. Forquer, P.F. Lin, and S.S. Lo FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
25. D. Coon, A.S. Gokhale, S.A. Burton, D.E. Heron, C. Ozhasoglu, and N. Christie Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning Clin Lung Cancer 9 2008 217 221